News
Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...
Hims & Hers (HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk (NVO) announced a partnership with ...
Before taking a GLP-1, my usual breakfast would rely on carb-heavy items like a bagel with cream cheese, but now I prioritize ...
Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...
Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg ...
TD Cowen downgraded Hims & Hers Health to "Hold" from "Buy" citing a lack of near-term catalysts and concerns over the company’s weight loss revenue guidance in a post-compounded GLP-1 ...
SHOPPING: Take steps to achieve your body goals with Hers, the weight loss program that takes into account your specific ...
Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...
In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering will launch this week ...
While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...
Millions of Americans are turning to popular GLP-1 drugs to help them lose weight — and while many have found weight loss success while taking these medicines, the number on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results